Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Multicenter Trial of 68Ga-PSMA-11 PET/CT Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning [PSMA-SRT]

NCT03582774 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT03582774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03582774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Multicenter Trial of 68Ga-PSMA-11 PET/CT Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning [PSMA-SRT]
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 12, 2018
Completion date
July 12, 2028
Enrollment
193 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent prostate carcinoma